Opinion: Fairness in liver transplants can be a constitutional issue

Understanding claims that denial of an organ transplant violates an individual's constitutional rights can identify ways to limit discrimination and exclusion and improve the fairness of organ allocation.

Liver failure is a terrible way to die: a painful belly full of fluid, vomiting blood, mental confusion, and repeated hospitalizations. The only cure is liver transplantation but, as is the case for all types of transplants, there aren’t nearly enough donor livers to go around.

This shortage raises two important questions: Who should receive a transplant? And what rights do transplant candidates have?

Choosing who gets a transplant is among the most charged and challenging tasks of modern medicine. In the U.S., about from all forms liver disease each year; more than 8,000 get liver transplants. Even those these individuals are so sick that no operation other than transplantation itself would be considered safe, 90% of liver transplant recipients survive the year after transplant, and . The cost of

Vous lisez un aperçu, inscrivez-vous pour en lire plus.

Plus de STAT

STAT1 min de lecture
Sharon Begley, Path-breaking Science Journalist Who Spun Words Into Gold, Dies At 64
From the glory days of print magazines to 2020’s Twitter-crazed news cycles, Sharon Begley won more awards and accolades than could fit in an obituary. The accomplishments she was prouder…
STAT1 min de lectureMedical
STAT+: Pharmalittle: Pfizer And BioNTech Say Vaccine Is Effective Against Covid-19 Variant; U.S. To Join COVAX Initiative
The Pfizer-BioNTech Covid-19 vaccine appears to work just as well against a fast-spreading variant first identified in the U.K. as it does against earlier forms of the coronavirus.
STAT1 min de lectureAmerican Government
STAT+: Pharmalittle: Biden Taps Kessler To Lead Operation Warp Speed; Trump Administration Seeks Term Limits On Top FDA, CDC Scientists
President-elect Joe Biden has chosen David Kessler to help lead Operation Warp Speed, the program to accelerate development of Covid-19 vaccines and treatments.